{"id":141931,"name":"BRAIDWOOD MANAGEMENT, INC.","slug":"braidwood-management-inc","state":"TX","country":"United States of America","description":"Management company.","totalSpending":321000,"filings":29,"yearlySpending":[{"year":2018,"income":45000},{"year":2019,"income":45000},{"year":2020,"income":67500},{"year":2021,"income":45000},{"year":2022,"income":45000},{"year":2023,"income":33750},{"year":2024,"income":39750}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"PHA","display":"Pharmacy"}],"firms":["ROCK & ASSOCIATES"],"lobbyists":["JAMES ROCK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Patient Access to Compounded Medications Act of 2017.","Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.","Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Patient Access to Compounded Medications Act of 2017.","Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018."]}